Global LAA closure market set to grow at a CAGR of 28% by 2020, says Technavio

Renewable energy

 

A complete analysis and breakdown of the left atrial appendage closure market by product (epicardial LAA closure device and endocardial LAA closure device) and by geography (the Americas, EMEA, and APAC). The report presents the vendor landscape and a corresponding detailed study of the key vendors in the market, including AtriCure, Boston Scientific, St. Jude, and Coherex Medical.

Technavio has released its new market research report, global LAA closure market, which is expected to generate revenues of $936 billion between 2016 and 2020. One of the major factors driving the growth of LAA closure market is increasing incidences of atrial fibrillation and strokes among the elderly population. The EMEA region is the highest revenue generator in the LAA closure market, accounting for 52% of the overall market revenue. The market in the EMEA is expected to continue its growth during the forecast period and this is attributed to increase in the incidence of strokes and the growing elderly population. Stroke alone accounts for 1.1 million deaths in Europe every year.

“LAA closure devices are non-invasive, which offers a novel approach for stroke treatment. LAA closure device treatment is cost-effective as they are a one-time investment treatment. Moreover, the market is observing increase in vascular treatments and surgeries with new product approvals for LAA closure devices. Also, the market is expecting positive reimbursement coverage for LAA closure devices over the next few years,” says Brahadeesh Chandrasekaran, Lead Analyst, Healthcare & Lifesciences, Technavio Research.

Endocardial involves implantation of a device to occlude the LAA. Endocardial LAA closure devices are implanted through a transseptal approach under TEE technique. A specific delivery system has been developed for each device type allowing for repositioning, collapse, or removal in the event of suboptimal results.

The key vendors in the global LAA closure market are AtriCure, Boston Scientific, St. Jude, and Coherex Medical. The market witness the presence of very few market vendors, hence the competition in the market is moderate at present. However, the competition is expected to intensify with new product launches. Also, there is a vast opportunity for the market to grow significantly in the Americas in the forecast period.

A more detailed analysis is available in the Technavio report, Global LAA Closure Market 2016-2020.

We can customize this reports by other regions and specific segments upon request.

Other related reports: